PHARMACOVIGILANCE (PV) EXECUTIVE AT CHANRAI HEALTH CARE LIMITED

About Company:

Chanrai Health Care Limited is a healthcare company that was incorporated in Lagos, Nigeria with Registration Number 963431. It was registered on 05 Jul 2011 and it's current status is unknown. 

Job Description:

• Establish and maintain Chanrai HealthCare’s Pharmacovigilance System in line with global standards and NAFDAC regulations.
• Collect, analyze, and evaluate safety data from various sources.
• Ensure timely reporting of adverse events and safety signals to relevant regulatory authorities.
• Maintain PV databases and ensure compliance with Good Pharmacovigilance Practices (GVP).
• Liaise with internal teams and external stakeholders to ensure product safety monitoring.
• Develop and implement SOPs, training materials, and awareness programs on PV across the organization.
• Prepare periodic safety update reports (PSURs) and other regulatory submissions.

Requirements:

• Minimum of 1–3 years hands-on experience in Pharmacovigilance or Drug Safety.
• Prior experience setting up or managing a PV system is a plus.
• Good understanding of PV principles, Good Pharmacovigilance Practice (GVP), and regulatory requirements (especially NAFDAC).
• Strong analytical and critical thinking ability to evaluate safety data and manage issues under pressure.
• Excellent written and verbal communication skills.
• High attention to detail and accuracy in data analysis and reporting.
• Ability to work independently while collaborating with cross-functional teams.

Qualifications and Skills:

• Minimum of a B.Sc. degree in Health Sciences (Pharmacology, Biochemistry, Biotechnology, Pharmacy, or related fields).
• Certification in Pharmacovigilance (PV) is a strong advantage.
• Strong computer and IT skills are desirable.

Salary

Application Closing Date: 09th October, 2025

Application Instructions:

Interested and qualified candidates should send their CV and cover letter to: careers@kewalramnigeria.com using "Pharmacovigilance Personnel – Lagos" as the subject of the mail.